LR

Lesley Russell

Chimeric Therapeutics Limited | Non-Executive Director
Dr Russell is a haematologist/oncologist and has over 25 years of experience and leadership in the international pharmaceutical field as a Chief Medical Officer. She has undertaken clinical development in several therapeutic areas including haematology/oncology and has had multiple new drug approvals with both FDA and European Medicines Agency. Dr Russell has experience as a director of NASDAQ listed pharmaceutical companies. She is a Member of the Risk Committee.

Companies and Roles

Company
Title
Tenure
Since
CHM
Chimeric Therapeutics Limited
  • Non-Executive Director
5yrs, 10mthAug 2020
IMU
Imugene Limited
  • Non-Executive Director
7yrs, 2mthApr 2019

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMU
Imugene Limited
01/07/26632,004500,0007,003N/A
CHM
Chimeric Therapeutics Limited
30/06/251,739,130N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMU
Imugene Limited
01/07/26
Exercise
7,353$0.140$1,029Conversion of securities
IMU
Imugene Limited
01/07/26
Buy
7,353$0.140$1,029Conversion of securities
IMU
Imugene Limited
30/06/26
Expiry
17,648$0.115$2,029Options expired
IMU
Imugene Limited
17/12/25
Issued
14,706$0.320$4,705Conversion of securities
IMU
Imugene Limited
17/12/25
Exercise
14,706$0.320$4,705Conversion of securities